相关实验视频

Updated: Jun 10, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

[循环瘤DNA在淋巴瘤中的进展和应用]

D Z Huang¹, X Zhang², J Rao¹

¹Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing Key Laboratory of Hematology and Microenvironment, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing 400037, China.

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

|October 16, 2024

概括

循环瘤DNA (ctDNA) 提供了淋巴瘤分析的非侵入性方法,克服了传统活检的局限性. 这种方法有助于分子分析,治疗监测和对淋巴瘤患者的生存预测.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

淋巴瘤是多样化的瘤,需要精确的分子分析.
目前的方法如组织活检在捕捉瘤异质性和负担方面存在局限性.
循环瘤DNA (ctDNA) 是一个有前途的,非侵入性的生物标志物.

研究的目的:

审查淋巴瘤中ctDNA分析方法.
描述不同淋巴瘤亚型的ctDNA应用.
突出ctDNA在淋巴瘤患者临床决策中的潜力.

主要方法:

对淋巴瘤中ctDNA分析现有文献的综述.
对ctDNA应用的分析,包括体变异基因型定型,治疗监测和最小残留疾病检测.
探索ctDNA在生存预测中的作用.

主要成果:

ctDNA测试对各种淋巴瘤亚型具有敏感性和特异性.
ctDNA分析有助于进行非侵入性分子分析和监测.
ctDNA有助于评估治疗疗效和预测患者的存活率.

结论:

ctDNA是用于淋巴瘤诊断和管理的多功能生物标志物.
非侵入性ctDNA测试克服了传统活检的局限性.
ctDNA分析可以显著改善淋巴瘤护理中的临床决策.

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...